Formulation comprising liquid ester quats and/or imidazolinium salts and polymer thickeners

US9763870B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9763870-B2
Application numberUS-201514861380-A
CountryUS
Kind codeB2
Filing dateSep 22, 2015
Priority dateSep 22, 2014
Publication dateSep 19, 2017
Grant dateSep 19, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to formulations containing liquid ester quats and/or imidazolinium salts and polymer thickeners and to the use thereof.

First claim

Opening claim text (preview).

What is claimed as new is: 1. A formulation comprising: A) at least one liquid ester quat, and B) at least one polymer thickener, wherein the liquid ester quat comprises at least one compound of general formula I) where R 1 is an acyl residue of an at least monounsaturated fatty acid having a chain length of 18 to 24 carbon atoms or the acyl residue of isostearic acid or ricinoleic acid, where R 2 is an alkyl residue having 1 to 6 carbon atoms, where a=1 to 3 and b=1 to 3, with the proviso that a+b=4. 2. The formulation according to claim 1 , further comprising: at least one compound of general formula Ia) where R 1a is an acyl residue of a carboxylic acid different from the carboxylic acid defined for R 1 , wherein R 1 is an acyl residue of an at least monounsaturated fatty acid having a chain length of 18 to 24 carbon atoms or the acyl residue of isostearic acid or ricinoleic acid, and where R 2b is an alkyl residue having 1 to 6 carbon atoms, where c=1 to 3 and d=1 to 3 with the proviso that c+d=4. 3. The formulation according to claim 1 , further comprising a liquid imidazolinium salt, wherein the liquid imidazolinium salt is selected from the group consisting of 1-alkylamidoimidazolinium and 1-alkoxyalkylimidazolinium salts of general formulae (II) and (III) where R 3 is an optionally branched, optionally unsaturated alkyl residue having 1 to 30 carbon atoms optionally interrupted by oxygen atoms, R 4 are each independently hydrogen or alkyl, R 5 is a divalent, saturated or unsaturated, straight-chain, branched or cyclic, optionally substituted hydrocarbon residue and optionally interrupted by oxygen atoms, nitrogen atoms or carboxyl groups, R 6 is hydrogen or an optionally branched, optionally unsaturated alkyl residue, optionally comprising oxygen atoms or nitrogen atoms, having 1 to 30 carbon atoms, and A is a counterion to the positive charges on the quaternary nitrogen groups. 4. The formulation according to claim 1 , wherein component A) is present in an amount of 0.1 to 7% by weight, wherein the percentages by weight refer to the overall formulation. 5. The formulation according to claim 1 , wherein the polymer thickener is selected from the group consisting of natural thickeners, modified natural products, and fully synthetic polymers, thickeners based on silicates or modified aluminas or derivatives thereof and cationic/cationized polymers. 6. The formulation according to claim 1 , wherein the polymer thickener is selected from the group consisting of polyacrylate-based thickeners. 7. The formulation according to claim 1 , wherein component B) is present in an amount of 0.005% by weight to 2% by weight, based on the overall formulation. 8. The formulation according to claim 1 , wherein the formulation is an emulsion. 9. The formulation according to claim 1 , further comprising: C) at least one fatty alcohol. 10. The formulation according to claim 9 , wherein the fatty alcohol is selected from the group consisting of octanol, decanol, lauryl alcohol, isolauryl alcohol, anteisolauryl alcohol, myristyl alcohol, isomyristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, anteisostearyl alcohol, eicosanol, petroselinyl alcohol, Guerbet alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, hectacosanol, octacosanol, melissyl alcohol, and mixtures thereof. 11. The formulation according to claim 9 , wherein component C) is present in an amount of 0.5 to 20% by weight, based on the overall formulation. 12. The formulation according to claim 9 , further comprising: D) at least one emulsifier. 13. The formulation according to claim 12 , wherein component A) is present in an amount of 0.1 to 7% by weight, component B) is present in an amount of 0.005% by weight to 2% by weight, component C) is present in an amount of 0.5 to 20% by weight, and component D) is present in an amount of 0.1 to 10% by weight, based in each case on the overall formulation.

Assignees

Inventors

Classifications

  • Oil-in-water emulsions · CPC title

  • A61K8/4946Primary

    Imidazoles or their condensed derivatives, e.g. benzimidazoles · CPC title

  • A61K8/416Primary

    Quaternary ammonium compounds (A61K8/35 takes precedence) · CPC title

  • Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers · CPC title

  • Cellulose; Quaternized cellulose derivatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9763870B2 cover?
The invention relates to formulations containing liquid ester quats and/or imidazolinium salts and polymer thickeners and to the use thereof.
Who is the assignee on this patent?
Evonik Degussa Gmbh
What technology area does this patent fall under?
Primary CPC classification A61K8/4946. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).